TYRA-200

· Tyra Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TYRA-200, covering 2024-10-03 to 2024-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations [Phase 1]

See pricing